Loading viewer...
investor_presentation
Format: PDF investor_presentation
Longboard Pharmaceuticals investor presentation dated September 2022.
September 2022Forward -Looking Statements
This presentation contains forward -looking statements about Longboard Pharmaceuticals, Inc.(“we,”“Longboard” orthe“Company”), including statements
regarding :ourfuture results ofoperations and financial position ;business strategy ;thetiming, costs and conduct ofourpreclinical studies and clinical trials for
our product candidates ;thetiming and likelihood ofregulatory filings and approvals forour product candidates ;our intellectual property ;our ability to
commercialize ourproduct candidates, ifapproved ;and other statements that arenothistorical facts, including statements that may include words such as“will”,
“may”,“can”,“intend”, “plan”,“expect”, “believe”, “potential” and similar words .For such statements, weclaim theprotection ofthePrivate Securities
Litigation Reform Actof1995 .These forward -looking statements aresubject toanumber ofrisks, uncertainties and assumptions, including, butnotlimited to:our
limited operating history ;netlosses ;our expectation that wewill incur netlosses fortheforeseeable future, and that wemay never beprofitable ;our need for
additional funding and related risks forourbusiness, product development programs and future commercialization activities ;thetiming and success ofclinical
trials weconduct ;theability toobtain and maintain regulatory approval ofour product candidates ;theability tocommercialize our product candidates ;our
ability tocompete inthemarketplace ;risks regarding ourlicense and dependencies onothers ;ourability toobtain and maintain intellectual property protection
and freedom tooperate forourproduct candidates ;ourability tomanage ourgrowth ;and other risks and factors disclosed inourfilings with theU.S.Securities
and Exchange Commission .Weoperate inavery competitive and rapidly changing environment .New risks emerge from time totime .Itisnotpossible forour
management topredict allrisks, norcanweassess theimpact ofallfactors onourbusiness ortheextent towhich any factor, orcombination offactors, may cause
actual results todiffer materially from those contained inany forward -looking statements wemay make .The forward -looking events and circumstances
discussed inthis presentation may notoccur and actual results could differ materially and adversely from those anticipated orimplied intheforward -looking
statements .Except asrequired bylaw, weassume noresponsibility fortheaccuracy and completeness oftheforward -looking statements, and weundertake no
obligation toupdate any forward -looking statements after thedate ofthis presentation toconform these statements toactual results ortochanges inour
Certain information contained inthis presentation and statements made orally during this presentation relate toorarebased onstudies, publications, surveys
investor_presentation
Aegis Logistics Limited
and other data obtained from third -party sources andLongboard’s own internal estimates and research .While Longboard believes these third -party studies,
Preview truncated — download the full document for the complete content.
investor_presentation
30 Pages
Teva Pharmaceutical Industries Investor Presentation — November 2022
investor_presentationinvestor_presentation
39 Pages
Teva Pharmaceutical Industries
Virpax Pharmaceuticals VRPX 2024 Investor Presentation
investor_presentationinvestor_presentation
29 Pages
Virpax Pharmaceuticals, Inc.